Lam Research
LRCX
$319.29
-0.84%
Lam Research is a leading supplier of semiconductor wafer fabrication equipment, specializing in deposition and etch processes essential for manufacturing advanced chips. It holds the top market share in etch and the clear second position in deposition, serving the world's largest chipmakers including TSMC, Samsung, Intel, and Micron. The stock is currently driven by the AI infrastructure build-out, which is fueling demand for its capital equipment, as evidenced by record quarterly revenue and a bullish outlook. Recent news highlights both the potential for Lam to reach a $1 trillion market cap and the risk of overvaluation in AI-related sectors, creating a debate around growth sustainability.…
LRCX
Lam Research
$319.29
Related headlines
Investment Opinion: Should I buy LRCX Today?
Rating: Buy. Lam Research is a high-quality growth stock benefiting from secular AI demand, with strong financials and a reasonable trailing P/E of 23.3x. The analyst consensus is 'strong buy' with an average target of $366.48, implying 17% upside.
Supporting Evidence: The trailing P/E of 23.3x is only a 6% premium to the semiconductor industry average of 22x, which is justified by superior growth (23.8% YoY revenue growth) and profitability (net margin 31.2% vs. industry average ~20%). Free cash flow of $6.45B TTM provides a 5.2% FCF yield, and the ROE of 54.3% is exceptional. The PEG ratio of 0.54 suggests the stock is undervalued relative to its earnings growth rate.
Risks & Conditions: The primary risk is the forward P/E of 38.8x, which could compress if growth decelerates. This Buy rating would be downgraded to Hold if revenue growth falls below 15% or if the trailing P/E exceeds 30x. Conversely, it would be upgraded to Strong Buy if the stock pulls back to $280 (trailing P/E ~20x) or if forward guidance accelerates. Overall, Lam Research appears fairly valued on trailing earnings but overvalued on forward earnings, making it a buy for growth-oriented investors with a 12-month horizon.
Sign up to view all
LRCX 12-Month Price Forecast
Lam Research is well-positioned to benefit from the multi-year AI infrastructure build-out, with strong revenue growth, expanding margins, and a solid balance sheet. The trailing valuation is reasonable, but the forward P/E of 38.8x implies high expectations that could lead to volatility if growth disappoints. The base case of 15-20% growth and a target of $366 is most likely, but the bull case of $500 is achievable if AI demand accelerates. The stance is bullish with medium confidence due to the elevated forward multiple and cyclical risks. An upgrade to high confidence would require sustained revenue growth above 25% and a pullback in the forward P/E to 30x.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $368.26 and implied upside of +15.3% versus the current price.
Average Target
$368.26
0 analysts
Implied Upside
+15.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$220 - $500
Analyst target range
Lam Research is covered by 31 analysts, with a consensus recommendation of 'strong buy' (mean rating of 1.49 on a 1-5 scale). The average price target is $366.48, implying approximately 17.0% upside from the current price of $313.30. The distribution leans heavily bullish, with recent ratings from firms like Needham, Stifel, Mizuho, and TD Cowen all maintaining Buy or Outperform ratings. The target range spans from a low of $220.00 to a high of $500.00, indicating significant dispersion in analyst views. The high target of $500.00 assumes continued AI-driven demand acceleration and potential multiple expansion, while the low target of $220.00 factors in risks such as cyclical downturns in semiconductor capital spending or geopolitical disruptions. The wide spread ($280) reflects high uncertainty around the pace and sustainability of the AI cycle. Recent institutional ratings show no downgrades, with firms like Morgan Stanley, B of A Securities, and Citigroup reiterating Overweight or Buy ratings, reinforcing the bullish consensus.
Bulls vs Bears: LRCX Investment Factors
Lam Research presents a compelling bull case driven by accelerating revenue growth (23.8% YoY), expanding margins (net margin 31.2%), and a dominant position in semiconductor etch and deposition equipment critical for AI chips. The strong free cash flow ($6.45B TTM) and bullish analyst consensus (strong buy, 17% upside to average target) support the positive thesis. However, the forward P/E of 38.8x is a significant premium to the industry average, and the stock's high beta (1.805) and recent 16.3% monthly decline highlight valuation and volatility risks. The single most important tension is whether AI-driven demand can sustain the growth trajectory needed to justify the elevated forward multiple, or if a cyclical slowdown or geopolitical shock will trigger multiple compression and downside.
Bullish
- Accelerating Revenue Growth: Revenue grew 23.8% YoY to $5.84B in Q3 FY2026, accelerating from 13.7% in the prior quarter. This is driven by AI infrastructure demand, with record quarterly revenue reported.
- Expanding Profit Margins: Net margin improved to 31.2% in Q3 FY2026 from 28.2% a year ago, while operating margin reached 35.0%. This demonstrates strong operating leverage as revenue scales.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow is $6.45B, providing a FCF yield of approximately 5.2%. This supports dividends, buybacks, and internal investment.
- Bullish Analyst Consensus: 31 analysts rate the stock a 'strong buy' with a mean rating of 1.49. The average price target of $366.48 implies 17.0% upside from the current price of $313.30.
Bearish
- Elevated Forward P/E Multiple: The forward P/E of 38.8x represents a 76% premium to the semiconductor industry average of 22x. This leaves little room for error and exposes the stock to multiple compression if growth disappoints.
- High Beta and Recent Pullback: With a beta of 1.805, the stock is 80.5% more volatile than the market. It has declined 16.3% in the past month, underperforming the S&P 500 by 16.6%, signaling potential profit-taking or sentiment shift.
- Cyclical Semiconductor Industry Risk: The semiconductor equipment industry is inherently cyclical. A downturn in chip demand or a pause in AI capex could lead to sharp revenue declines, as seen in prior cycles.
- Geopolitical and Trade Tensions: Exposure to memory chipmakers (DRAM/NAND) and customers in Asia makes Lam vulnerable to US-China trade restrictions or geopolitical disruptions, which could impact supply chains and demand.
LRCX Technical Analysis
Lam Research is in a powerful long-term uptrend, with the stock up 210.8% over the past year, dramatically outperforming the S&P 500's 18.4% gain. The current price of $313.30 sits at 71.4% of its 52-week range ($90.94–$438.50), indicating the stock is still well above its lows but has pulled back from the highs, suggesting a consolidation phase rather than a trend reversal. The 1-year relative strength of +192.5% versus the S&P 500 underscores Lam's leadership in the semiconductor equipment space. Short-term momentum has diverged sharply from the long-term trend: the stock has declined 16.3% over the past month while the S&P 500 gained 0.3%, yet it remains up 17.1% over the past three months. This 1-month pullback could signal a temporary correction within a broader uptrend, possibly driven by profit-taking or 'sell the news' events after strong earnings. The beta of 1.805 indicates the stock is 80.5% more volatile than the market, amplifying both upside and downside moves. Key support lies near the 52-week low of $90.94, though a more immediate floor may form around the recent low of $313.30. Resistance is at the 52-week high of $438.50; a breakout above that level would signal renewed momentum and potentially a test of all-time highs. A breakdown below $313.30 could lead to a deeper correction toward the $300 area.
Beta
1.80
1.80x market volatility
Max Drawdown
-29.2%
Largest decline past year
52-Week Range
$91-$439
Price range past year
Annual Return
+226.8%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | -22.0% | +0.4% |
| 3m | +23.5% | +5.5% |
| 6m | +46.5% | +8.4% |
| 1y | +226.8% | +18.9% |
| ytd | +72.5% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Lam Research's revenue trajectory is accelerating strongly, with Q3 FY2026 (ending March 29, 2026) revenue of $5.84 billion, up 23.8% year-over-year. This marks a significant acceleration from the prior year's Q3 revenue of $4.72 billion and continues a multi-quarter growth trend from $3.87 billion in Q4 FY2024. The growth is driven by both System revenue ($3.73 billion) and Customer Support & Other ($2.11 billion), reflecting broad-based demand from AI chip manufacturing. The revenue growth trajectory supports the investment case for Lam as a key beneficiary of the AI infrastructure build-out. Profitability is robust and improving: net income for Q3 FY2026 was $1.83 billion, with a net margin of 31.2%, up from 28.2% in the year-ago quarter. Gross margin expanded to 49.8% from 49.0% a year earlier, while operating margin reached 35.0%, demonstrating operating leverage. The company is solidly profitable with a trailing P/E of 23.3x, and margins are above typical semiconductor equipment industry averages, reflecting its competitive advantages. Lam Research maintains a strong balance sheet with a current ratio of 2.21 and a debt-to-equity ratio of 0.48, indicating low financial risk. Free cash flow for the trailing twelve months was $6.45 billion, providing ample liquidity for internal growth, dividends, and share buybacks. The ROE of 54.3% is exceptional, reflecting efficient capital use, while the FCF yield of approximately 5.2% (based on current market cap of $125.2 billion) offers a solid cash return to shareholders.
Quarterly Revenue
$5.8B
2026-03
Revenue YoY Growth
+23.8%
YoY Comparison
Gross Margin
49.8%
Latest Quarter
Free Cash Flow
$6.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 23.3x, while the forward P/E is 38.8x, implying the market expects significant earnings growth ahead—consistent with the AI-driven demand narrative. The gap between trailing and forward P/E suggests investors are pricing in a sharp earnings acceleration. Compared to the semiconductor industry average P/E of approximately 22x (based on sector data), Lam's trailing P/E of 23.3x is only a 6% premium, which appears justified given its superior growth and profitability. However, the forward P/E of 38.8x represents a 76% premium to the industry forward average of 22x, indicating that the market is already discounting aggressive future growth. Historically, Lam's trailing P/E has ranged from 8.9x (in Q1 FY2023) to 34.2x (in Q3 FY2026). The current 23.3x is near the middle of this range, suggesting it is not excessively overvalued by historical standards. However, the forward P/E is near the high end of historical forward multiples, implying that any disappointment in earnings growth could lead to multiple compression.
PE
23.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Lam Research carries a debt-to-equity ratio of 0.48, which is manageable, but the forward P/E of 38.8x implies high earnings growth expectations. If revenue growth decelerates from the current 23.8% YoY, the stock could face multiple compression. The net margin of 31.2% is strong, but any margin pressure from rising R&D costs ($583M in Q3) or competitive pricing could erode profitability. Free cash flow of $6.45B TTM provides a cushion, but the high payout ratio (21.5%) and dividend yield (0.9%) are modest, limiting income appeal.
Market & Competitive Risks: The stock's beta of 1.805 makes it highly sensitive to market downturns, and the recent 16.3% monthly decline relative to the S&P 500's gain of 0.3% highlights this vulnerability. The semiconductor equipment industry is cyclical, and a slowdown in AI capex or a shift to less capital-intensive chip architectures could reduce demand. Geopolitical risks, such as US export controls on China, could disrupt sales to key customers like SMIC or Huawei. Recent news about Samsung's strong earnings triggering a 'sell the news' event suggests the market may be pricing in overvaluation in AI-related sectors.
Worst-Case Scenario: In a severe downturn, Lam's revenue could decline 30-40% as seen in prior cycles, and the stock could fall to the analyst low target of $220, representing a 29.8% decline from the current price of $313.30. The 52-week low of $90.94 is an extreme downside, implying a 71% loss, but this would require a catastrophic industry collapse. A more realistic worst-case scenario is a 30% drop to $220, driven by a cyclical downturn and multiple compression from 23x trailing P/E to 15x.
FAQ
The key risks are: 1) Valuation risk: The forward P/E of 38.8x leaves little room for error; a growth slowdown could trigger multiple compression. 2) Cyclical risk: Semiconductor equipment is cyclical; a downturn in chip demand could reduce revenue by 30-40% as seen in prior cycles. 3) Geopolitical risk: US-China trade tensions could restrict sales to Chinese customers, who are a significant part of the market. 4) Competitive risk: While Lam leads in etch, competition from Applied Materials and Tokyo Electron could pressure market share. The most severe risk is a 30% decline to the analyst low target of $220 if a cyclical downturn materializes.
The 12-month forecast is based on three scenarios: Bull case (25% probability) targets $400-$500, driven by accelerating AI demand and multiple expansion. Base case (50% probability) targets $330-$400, with revenue growth moderating to 15-20% and the stock trading near the analyst average of $366. Bear case (25% probability) targets $220-$280, driven by a cyclical downturn or geopolitical shock. The base case is most likely, assuming AI demand remains strong but growth decelerates. The analyst consensus is 'strong buy' with an average target of $366.48, implying 17% upside from the current price of $313.30.
Lam Research's trailing P/E of 23.3x is only a 6% premium to the semiconductor industry average of 22x, suggesting it is fairly valued on past earnings. However, the forward P/E of 38.8x represents a 76% premium, indicating the market is pricing in aggressive future growth. The PEG ratio of 0.54 suggests undervaluation relative to earnings growth, but this depends on sustained high growth. Compared to its own history, the trailing P/E is near the middle of its 5-year range (8.9x-34.2x), while the forward P/E is near the high end. Overall, the stock appears fairly valued on trailing metrics but overvalued on forward expectations, implying that any growth disappointment could lead to a correction.
Lam Research is a good buy for growth investors with a 12-month horizon, given its 17% upside to the analyst average target of $366.48 and strong fundamentals (23.8% revenue growth, 31.2% net margin). However, the forward P/E of 38.8x is elevated, making it vulnerable to multiple compression if growth slows. The stock is best suited for those who can tolerate high volatility (beta 1.805) and cyclical risk. For long-term investors, the trailing P/E of 23.3x is reasonable, and the company's competitive moat in semiconductor equipment supports sustained growth. The biggest downside risk is a 30% decline to $220 in a bear case scenario.
Lam Research is suitable for both, but with different risk profiles. For long-term investors (3-5 years), the company's dominant market position in semiconductor equipment and exposure to secular AI growth make it a compelling hold, with a trailing P/E of 23.3x and a 5.2% FCF yield providing a margin of safety. For short-term traders, the high beta (1.805) and recent 16.3% monthly decline offer opportunities for mean reversion, but the stock's volatility (52-week range $90.94-$438.50) requires active risk management. The dividend yield of 0.9% is minimal, so income-focused investors should look elsewhere. A minimum holding period of 12 months is recommended to ride out cyclical fluctuations.